Heart Test Laboratories (Heart Test Laboratories) Debt-to-Equity : 0.12 (As of Jan. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Heart Test Laboratories Debt-to-Equity?

Heart Test Laboratories's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was $0.60 Mil. Heart Test Laboratories's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was $0.46 Mil. Heart Test Laboratories's Total Stockholders Equity for the quarter that ended in Jan. 2024 was $8.63 Mil. Heart Test Laboratories's debt to equity for the quarter that ended in Jan. 2024 was 0.12.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Heart Test Laboratories's Debt-to-Equity or its related term are showing as below:

HSCS' s Debt-to-Equity Range Over the Past 10 Years
Min: -6.51 Med: -1.02 Max: 6.78
Current: 0.12

During the past 4 years, the highest Debt-to-Equity Ratio of Heart Test Laboratories was 6.78. The lowest was -6.51. And the median was -1.02.

HSCS's Debt-to-Equity is ranked better than
65.19% of 698 companies
in the Medical Devices & Instruments industry
Industry Median: 0.215 vs HSCS: 0.12

Heart Test Laboratories Debt-to-Equity Historical Data

The historical data trend for Heart Test Laboratories's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heart Test Laboratories Debt-to-Equity Chart

Heart Test Laboratories Annual Data

Trend

Apr20

Apr21

Apr22

Apr23

Debt-to-Equity

2.98

-1.61

-1.02

6.78

Heart Test Laboratories Quarterly Data
	Apr20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Debt-to-Equity	Get a 7-Day Free Trial									-6.51	6.78	-3.04	-1.21	0.12

Competitive Comparison of Heart Test Laboratories's Debt-to-Equity

For the Medical Devices subindustry, Heart Test Laboratories's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Heart Test Laboratories's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Heart Test Laboratories's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Heart Test Laboratories's Debt-to-Equity falls into.

Heart Test Laboratories Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Heart Test Laboratories's Debt to Equity Ratio for the fiscal year that ended in Apr. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.53	+	1.036)	/	0.231
	=	6.78

Heart Test Laboratories's Debt to Equity Ratio for the quarter that ended in Jan. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.598	+	0.461)	/	8.634
	=	0.12

Heart Test Laboratories (NAS:HSCS) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Heart Test Laboratories Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Heart Test Laboratories's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Heart Test Laboratories (Heart Test Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Heart Test Laboratories Inc (NAS:HSCS) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

550 Reserve Street, Suite 360, Southlake, TX, USA, 76092

Website

https://www.heartsciences.com

Heart Test Laboratories Inc is a medical technology company focused on applying innovative AI-based technology to an ECG to expand and improve an ECG's clinical usefulness. The objective of the company is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings.

Executives

David R. Wells	director	2801 OCEAN PARK BLVD., SUITE 339, SANTA MONICA CA 90405
Bruce Bent	director	750 BONHAM PARKWAY, LANTANA TX 76226
Mark T Hilz	director, officer: See Remarks	3301 DAKOTA DRIVE, NORTHLAKE TX 76226
Patrick Kanouff	director	550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Brian Szymczak	director	550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Danielle Watson	officer: See Remarks	550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Andrew Simpson	director, officer: See Remarks	550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092